Trump's Autism Announcement: Unveiling Controversial Findings
President Donald Trump announced plans for a significant disclosure on autism. An anticipated announcement, reportedly by Health Secretary Robert F. Kennedy Jr., may link Kenvue's Tylenol use during pregnancy to autism, challenging current medical guidelines. Trump's remarks hinted at a pivotal government initiative in autism research.
Devdiscourse News Desk | Washington DC | Updated: 21-09-2025 06:35 IST | Created: 21-09-2025 06:35 IST
- Country:
- United States
On Saturday, U.S. President Donald Trump indicated that his administration would make a significant announcement on autism findings on Monday, stirring curiosity and anticipation.
Refusing to divulge details, Trump hinted at the gravity of the upcoming revelation, describing it as potentially among his administration's key actions.
This follows a Wall Street Journal report revealing plans by Health Secretary Robert F. Kennedy Jr. to suggest Kenvue's Tylenol use in pregnancy may link to autism, opposing existing medical guidelines.
Advertisement
Google News